I've been reasonably cool with the SP drop, but today is probably the first time I'm a bit baffled.
The directors who spent $500,000 on market, plus GG all bought at $0.85 (Bell) or above (GG).
With the SP rapidly heading down, and no seeming response from the MSB Chairperson I have to surmise that they are confident of approval from the FDA and are content to reap rewards later.
$1.30 to $0.95 is a bit crap though tbh.
I wonder when company / top 20 support will kick in, as I doubt any CR will be done at this price.
Meh.
I've been reasonably cool with the SP drop, but today is...
-
- There are more pages in this discussion • 350 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
94.5¢ |
Change
-0.025(2.58%) |
Mkt cap ! $1.078B | |||
| Open | High | Low | Value | Volume |
| 98.0¢ | 98.5¢ | 94.0¢ | $2.482M | 2.602M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 71720 | 94.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 94.5¢ | 10463 | 1 |
View Market Depth
| Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |